NCT01558830View on ClinicalTrials.gov

Safety of Amiodarone and Ranolazine Together in Patients With Angina

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

July 31, 2013

Conditions
Chronic Stable AnginaCoronary Artery DiseaseAtrial FibrillationVentricular Tachycardia
Interventions
DRUG

ranolazine

ranolazine 500mg twice daily, may increase to 1000 mg twice daily for therapy optimization in treating chronic stable angina

DRUG

placebo

one pill twice daily, to increase to two pills twice daily to mirror standard ranolazine treatment strategy

Trial Locations (3)

89052

RECRUITING

Cardiovascular Consultants of Nevada, Henderson

89144

RECRUITING

Cardiovascular Consultants of Nevada, Las Vegas

89196

RECRUITING

Cardiovascular Consultants of Nevada, Las Vegas

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Cardiovascular Consultants of Nevada

OTHER